http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5793967-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_746d8243701ae4271b74368451625bee |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 |
filingDate | 1981-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4654f4fb508f73060395a0fbe9af7641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fb297c34603b4f7f60979ed8fb712bb |
publicationDate | 1982-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-S5793967-A |
titleOfInvention | Preparation of piperazine derivative |
abstract | NEW MATERIAL:The N-substituted trialkoxybenzylpiperazine deivatve of formulaI(R is methyl or ethyl; Z is diaminotriazine). n USE: Remedy for ischemic cardiopathy. It has various pharmacological actions to coronary circulatory system such as coronary vessel dilating action, cardiac motion suppressing action, etc. n PROCESS: The compound of formulaIis prepared by reacting the N-alkoxybenzylpiperazine of formula II with diaminohalogenotiazine in an inert solvent such as alcohol, dioxane, benzene, etc. at room temp. W100°C, if necessary in the presence of a proper acid acceptor. n COPYRIGHT: (C)1982,JPO&Japio |
priorityDate | 1981-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.